Drug Discovery,,Share: Written by:CAS Science TeamJune 21, 2022脂质纳米颗粒因其在两种已获批准的COVID mRNA疫苗中的作用而成为全球关注的焦点。但是,脂质纳米颗粒并不是独一无二的,事实上,它们的发展始于几十年前,是脂质体和关键的药物递送工具。直到现在,才出现了越来越多的进步和应用机会。下载 CAS 洞察报告Gain new perspectives for faster progress directly to your inbox.Subscribe to CAS Insights